Xiao-Hong Lu

"Xiao-Hong Lu"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tian X, Richard A, El-Saadi MW, et al. (2019) Dosage sensitivity intolerance of VIPR2 microduplication is disease causative to manifest schizophrenia-like phenotypes in a novel BAC transgenic mouse model. Molecular Psychiatry
Lu XH, Yang XW. (2017) Genetically-directed Sparse Neuronal Labeling in BAC Transgenic Mice through Mononucleotide Repeat Frameshift. Scientific Reports. 7: 43915
Xu J, Bernstein AM, Wong A, et al. (2016) P2X4 Receptor Reporter Mice: Sparse Brain Expression and Feeding-Related Presynaptic Facilitation in the Arcuate Nucleus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 8902-20
Langfelder P, Cantle JP, Chatzopoulou D, et al. (2016) Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice. Nature Neuroscience
Veldman MB, Rios-Galdamez Y, Lu XH, et al. (2015) The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington's disease model. Molecular Neurodegeneration. 10: 67
Peñagarikano O, Lázaro MT, Lu XH, et al. (2015) Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Science Translational Medicine. 7: 271ra8
Lu XH, Mattis VB, Wang N, et al. (2014) Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease. Science Translational Medicine. 6: 268ra178
Wang N, Gray M, Lu XH, et al. (2014) Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease. Nature Medicine. 20: 536-41
Haustein MD, Kracun S, Lu XH, et al. (2014) Conditions and constraints for astrocyte calcium signaling in the hippocampal mossy fiber pathway. Neuron. 82: 413-29
Wang N, Lu XH, Sandoval SV, et al. (2013) An independent study of the preclinical efficacy of C2-8 in the R6/2 transgenic mouse model of Huntington's disease. Journal of Huntington's Disease. 2: 443-51
See more...